Skip to main content
Menu
Public Information Hub
About Us
BAPRAS Information
About plastic surgery
Patient Information
Procedure Guides
News and Views
Professionals
Training and Education
Prizes, grants and fellowships
Research
Clinical Guidance and Regulations
JPRAS & JPRAS Open
e-LPRAS
UK National Flap Registry
Become a Member
Training and Education
Upcoming courses and events
BAPRAS Events
About Us
Find a Unit
Find a Member
Member Log in
Search
Home
Media & Government
News and Views
Silimed - Update from MHRA
Silimed - Update from MHRA
8
th
January 2016
The Medicines and Healthcare Products Regulatory Agency have published an update on the suspension of devices made by Silimed:
"We are contacting you to reiterate our previous advice about the harmonized European Competent Authorities’ position on the distribution of Silimed products. EU health experts are evaluating test results to establish if there are potential health risks associated with particles on the surface of these implants.
We are aware that Silimed have issued communications to suggest that there is no risk to patients however this is yet to be determined through our evaluation of testing. We will communicate the conclusions shortly. In the meantime our previous advice that devices should be quarantined continues to apply.
The CE suspension by Tüv Süd has been prolonged until the end of June 2016 due to the exceptional circumstances and occurrences in particular the fire in the main manufacturing site."
To view updates on Silimed, visit the
MHRA website
Back to list page
News and Views